"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. (2007)

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 17709549

Publication URI: http://europepmc.org/abstract/MED/17709549

Type: Journal Article/Review

Volume: 179

Parent Publication: Journal of immunology (Baltimore, Md. : 1950)

Issue: 5

ISSN: 0022-1767